A Study to Assess Retention Rate, Persistence and Adherence in Population of Spondylarthritis (Ankylosing Spondylitis and Psoriatic Arthritis) Patients Treated With Adalimumab in Routine Clinical Settings in Russian Federation
Study Identifier
P15-672
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete
Results Available
Scientific Result Summary
Available Language(s): English
Study Details
Medical Condition
Study Drug
N/A
Phase
N/A
Sex
Female & Male
Age
18 - 99 Years
Protocol Summary
The objective of this study is to access retention rate, persistence and adherence in population of spondylarthritis (SpA) (ankylosing spondylitis (AS) and psoriatic arthritis (PsA)) participants treated with adalimumab in routine clinical settings in the Russian Federation.
Study Locations
Location
Status
Location
Kemerovo Regional Clinical Hospital n.a. S.V. Belyaev /ID# 167025
Kemerovo, Kemerovo Oblast, Russian Federation, 650066
Status
Not applicable
Location
Clinical Hospital No.1 n.a. N.I.Pirogov /ID# 154379
Moscow, Moscow, Russian Federation, 119049
Status
Not applicable
Location
Ivanovo Regional Clinical Hosp /ID# 167028
Ivanovo, Russian Federation, 153040
Status
Not applicable
Location
Institution KhMAO-Ugra /ID# 154381
Khanty-Mansiysk, Russian Federation, 628011
Status
Not applicable
Location
State Clinical policlinic /ID# 154374
Moscow, Russian Federation, 107023
Status
Not applicable
Location
Central Research Institute /ID# 154375
Moscow, Russian Federation, 111123
Status
Not applicable
Showing {first} - {last} of {total} Results